日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are Limiting

增加丝氨酸合成为丝氨酸水平受限的组织中出现的肿瘤提供了优势

Mark R Sullivan, Katherine R Mattaini, Emily A Dennstedt, Anna A Nguyen, Sharanya Sivanand, Montana F Reilly, Katrina Meeth, Alexander Muir, Alicia M Darnell, Marcus W Bosenberg, Caroline A Lewis, Matthew G Vander Heiden

A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy

一种新型黑色素瘤免疫原性小鼠模型,用于联合靶向和免疫治疗的临床前评估

Emily J Lelliott, Carleen Cullinane, Claire A Martin, Rachael Walker, Kelly M Ramsbottom, Fernando Souza-Fonseca-Guimaraes, Shatha Abuhammad, Jessica Michie, Laura Kirby, Richard J Young, Alison Slater, Peter Lau, Katrina Meeth, Jane Oliaro, Nicole Haynes, Grant A McArthur, Karen E Sheppard

DKK2 imparts tumor immunity evasion through β-catenin-independent suppression of cytotoxic immune-cell activation

DKK2通过不依赖于β-catenin的途径抑制细胞毒性免疫细胞活化,从而赋予肿瘤免疫逃逸能力。

Qian Xiao ,Jibo Wu ,Wei-Jia Wang ,Shiyang Chen ,Yingxia Zheng ,Xiaoqing Yu ,Katrina Meeth ,Mahnaz Sahraei ,Alfred L M Bothwell ,Lieping Chen ,Marcus Bosenberg ,Jianfeng Chen ,Veronika Sexl ,Le Sun ,Lin Li ,Wenwen Tang ,Dianqing Wu

The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression

DNA甲基胞嘧啶双加氧酶Tet2维持肿瘤浸润髓系细胞的免疫抑制功能,从而促进黑色素瘤进展

Wen Pan ,Shu Zhu ,Kun Qu ,Katrina Meeth ,Jijun Cheng ,Kaixin He ,Hongdi Ma ,Yan Liao ,Xizhi Wen ,Christine Roden ,Zuzana Tobiasova ,Zheng Wei ,Jun Zhao ,Jun Liu ,Ji Zheng ,Bo Guo ,Sajid A Khan ,Marcus Bosenberg ,Richard A Flavell ,Jun Lu

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

衰老微环境中的sFRP2驱动黑色素瘤转移和治疗耐药性。

Amanpreet Kaur ,Marie R Webster ,Katie Marchbank ,Reeti Behera ,Abibatou Ndoye ,Curtis H Kugel 3rd ,Vanessa M Dang ,Jessica Appleton ,Michael P O'Connell ,Phil Cheng ,Alexander A Valiga ,Rachel Morissette ,Nazli B McDonnell ,Luigi Ferrucci ,Andrew V Kossenkov ,Katrina Meeth ,Hsin-Yao Tang ,Xiangfan Yin ,William H Wood 3rd ,Elin Lehrmann ,Kevin G Becker ,Keith T Flaherty ,Dennie T Frederick ,Jennifer A Wargo ,Zachary A Cooper ,Michael T Tetzlaff ,Courtney Hudgens ,Katherine M Aird ,Rugang Zhang ,Xiaowei Xu ,Qin Liu ,Edmund Bartlett ,Giorgos Karakousis ,Zeynep Eroglu ,Roger S Lo ,Matthew Chan ,Alexander M Menzies ,Georgina V Long ,Douglas B Johnson ,Jeffrey Sosman ,Bastian Schilling ,Dirk Schadendorf ,David W Speicher ,Marcus Bosenberg ,Antoni Ribas ,Ashani T Weeraratna

Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells

小鼠黑色素瘤同系模型对程序性细胞死亡-1 阻断的反应需要共刺激、CD4 和 CD8 T 细胞

Blanca Homet Moreno, Jesse M Zaretsky, Angel Garcia-Diaz, Jennifer Tsoi, Giulia Parisi, Lidia Robert, Katrina Meeth, Abibatou Ndoye, Marcus Bosenberg, Ashani T Weeraratna, Thomas G Graeber, Begoña Comin-Anduix, Siwen Hu-Lieskovan, Antoni Ribas

The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations

YUMM细胞系:一系列具有明确基因改变的同源小鼠黑色素瘤细胞系

Katrina Meeth ,Jake Xiao Wang ,Goran Micevic ,William Damsky ,Marcus W Bosenberg

mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation

mTORC1 激活可阻断 BrafV600E 诱导的生长停滞,但不足以形成黑色素瘤

William Damsky, Goran Micevic, Katrina Meeth, Viswanathan Muthusamy, David P Curley, Manjula Santhanakrishnan, Ildiko Erdelyi, James T Platt, Laura Huang, Nicholas Theodosakis, M Raza Zaidi, Scott Tighe, Michael A Davies, David Dankort, Martin McMahon, Glenn Merlino, Nabeel Bardeesy, Marcus Bosenber

PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets

PDK1 和 SGK3 促进 BRAF 突变型黑色素瘤的生长,是潜在的治疗靶点

Marzia Scortegagna, Eric Lau, Tongwu Zhang, Yongmei Feng, Chris Sereduk, Hongwei Yin, Surya K De, Katrina Meeth, James T Platt, Casey G Langdon, Ruth Halaban, Maurizio Pellecchia, Michael A Davies, Kevin Brown, David F Stern, Marcus Bosenberg, Ze'ev A Ronai